Metacrine Stock Price, News & Analysis
Company Description
Metacrine (OTC: MTCR) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $25.5M.
MTCR stock has gained 17.9% over the past year.
This page provides a comprehensive overview of MTCR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Metacrine (MTCR) stock. Over the past 12 months, the stock has gained 17.9%. At a market capitalization of $25.5M, MTCR is classified as a micro-cap stock with approximately 43.8M shares outstanding.
Latest News
Metacrine has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, earnings, management, clinical trial. View all MTCR news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MTCR Company Profile & Sector Positioning
Metacrine (MTCR) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.